Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vivosim Lab Inc (VIVS)

Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vivosim Lab Inc 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 USA

www.vivosim.ai Employees: 13 P: 858-224-1000

Sector:

Medical

Description:

VivoSim Labs Inc. is a clinical-stage biotechnology company. It involved in developing drugs which are demonstrated to be effective in three-dimensional human tissues as candidates for drug development. The company focuses on developing novel treatment approaches in inflammatory bowel disease. VivoSim Labs Inc., formerly known as Organovo Holdings Inc., is based in SAN DIEGO, United States.

Key Statistics

Overview:

Market Capitalization, $K 6,155
Enterprise Value, $K -5,155
Shares Outstanding, K 2,608
Annual Sales, $ 140 K
Annual Net Income, $ -2,480 K
Last Quarter Sales, $ 30 K
Last Quarter Net Income, $ -2,550 K
EBIT, $ -12,180 K
EBITDA, $ -11,910 K
60-Month Beta 1.27
% of Insider Shareholders 2.50%
% of Institutional Shareholders 8.23%
Float, K 2,543
% Float 97.50%
Short Volume Ratio 0.22

Growth:

1-Year Return -53.36%
3-Year Return -88.57%
5-Year Return -98.09%
5-Year Revenue Growth -93.64%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.98 on 11/06/25
Next Earnings Date 02/18/26
Earnings Per Share ttm -4.40
EPS Growth vs. Prev Qtr 14.04%
EPS Growth vs. Prev Year 41.69%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 03/21/25

VIVS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -28.83%
Return-on-Assets % -19.71%
Profit Margin % -1,771.43%
Debt/Equity 0.00
Price/Sales 43.29
Price/Cash Flow N/A
Price/Book 0.88
Book Value/Share 2.71
Interest Coverage -248.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar